Differential genomic profiling of the progesterone receptor (PR) negative and estrogen receptor (ER) low metastatic breast cancer subtypes through circulating tumor DNA: A TNBC-like disease subtype?

被引：0
|
作者：
Gerratana, Lorenzo
Davis, Andrew A.
Foffano, Lorenzo
Reduzzi, Carolina
Podany, Emily L.
Medford, Arielle J.
Clifton, Katherine
Velimirovic, Marko
Putur, Annika
Munoz-Arcos, Laura Sofia
Pontolillo, Letizia
Tapiavala, Shaili
Molteni, Elisabetta
Nicolo, Eleonora
Gradishar, William John
Ma, Cynthia X.
Andreopoulou, Eleni
Puglisi, Fabio
Bardia, Aditya
Cristofanilli, Massimo
机构：
[1] Univ Udine, Dept Med DMED, Aviano, Italy
[2] Washington Univ St Louis, St Louis, MO USA
[3] Univ Udine, Udine, Italy
[4] Weill Cornell Med, New York, NY USA
[5] Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA
[6] Washington Univ, Sch Med, St Louis, MO USA
[7] Cleveland Clin, Cleveland, OH USA
[8] Massachusetts Gen Hosp, Boston, MA USA
[9] Northwestern Univ, Div Hematol & Oncol, Dept Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA
[10] Univ Udine, Dept Med DAME, Udine, Italy
[11] Ctr Riferimento Oncol Aviano CRO, Dipartimento Oncol Medica, IRCCS, Udine, Italy
[12] UCLA Hlth Jonsson Comprehens Canc Ctr, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1039
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients
    Bahriye Aktas
    Sabine Kasimir-Bauer
    Volkmar Müller
    Wolfgang Janni
    Tanja Fehm
    Diethelm Wallwiener
    Klaus Pantel
    Mitra Tewes
    BMC Cancer, 16
  • [22] Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients
    Aktas, B.
    Kasimir-Bauer, S.
    Mueller, V.
    Rack, B.
    Janni, W.
    Pantel, K.
    Fehm, T.
    Tewes, M.
    CANCER RESEARCH, 2013, 73
  • [23] EVOLUTION OF ESTROGEN RECEPTOR (ER) AND ERBB2 EXPRESSION BETWEEN PRIMARY TUMOR AND CIRCULATING TUMOR CELLS (CTC) OF METASTATIC BREAST CANCER PATIENTS
    Doisneau-Sixou, S.
    Bock, C.
    Kuhn, C.
    Majunke, L.
    Jaeger, B.
    Theil, C.
    Jeschke, U.
    Rack, B.
    ANNALS OF ONCOLOGY, 2012, 23 : 25 - 25
  • [24] Metastatic Outcome of Estrogen Receptor (ER)-Negative Breast Cancer Appears Independent of Both Age-at-Onset and Tumor Proliferative Potential
    Yau, C.
    Zhang, Y.
    Wang, Y.
    Foekens, J. A.
    Benz, C.
    CANCER RESEARCH, 2009, 69 (24) : 723S - 724S
  • [25] Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status
    Xu, Ye
    Yao, Lihua
    Li, Hongxia
    Tao Ouyang
    Li, Jinfeng
    Wang, Tianfeng
    Fan, Zhaoqing
    Lin, Benyao
    Lu, Youyong
    Larsson, Olle
    Xie, Yuntao
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 97 (01) : 49 - 55
  • [26] Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status
    Ye Xu
    Lihua Yao
    Hongxia Li
    Tao Ouyang
    Jinfeng Li
    Tianfeng Wang
    Zhaoqing Fan
    Benyao Lin
    Youyong Lu
    Olle Larsson
    Yuntao Xie
    Breast Cancer Research and Treatment, 2006, 97 : 49 - 55
  • [27] Analysis of estrogen receptor-positive (ER1), progesterone-receptor negative (PR-) and Her-2/neu overexpression phenotype in breast cancer patients
    Montesa Pino, Alvaro
    Conde, Veronica
    Sanchez Toro, Carmen
    Luque Caro, Raquel
    Rodriguez Franco, Carlos
    Jimenez Pubiano, Berta
    Irigoyen, Antonio
    Gonzalez, Encarnacion
    Valdivia, Javier
    Ramon Delgado, J.
    ANNALS OF ONCOLOGY, 2006, 17 : 90 - 90
  • [28] Detection of activating estrogen receptor 1 (ESR1) in circulating tumor DNA (ctDNA) in hormone-receptor positive metastatic breast cancer (MBC)
    Austin, L.
    Rodriguez, A.
    Jaslow, R.
    Fortina, P.
    Nagy, R.
    Zill, O.
    Talasaz, A.
    Cristofanilli, M.
    CANCER RESEARCH, 2016, 76
  • [29] Circulating tumor DNA as a predictive biomarker of response to palbociclib-fulvestrant in patients with estrogen receptor-positive, HER2-negative metastatic breast cancer
    Darrigues, L.
    Pierga, J-Y
    Bernard, A.
    Bieche, I.
    Silveira, A.
    Michel, M.
    Sablin, M-P
    Cottu, P.
    Dubot, C.
    Geiss, R.
    Ricci, F.
    Proudhon, C.
    Bidard, F-C
    CANCER RESEARCH, 2019, 79 (04)
  • [30] Clinicopathologic characteristics and genomic essence analyses revealed estrogen receptor positive, progesterone receptor negative and human epidermal growth factor receptor 2 negative breast cancer to be more basal-like and endocrine resistant
    Liu, Xiyu
    Ma, Ding
    Jiang, Yi-Zhou
    Liu, Yi-Rong
    Yu, Ke-Da
    Shao, Zhi-Ming
    CANCER RESEARCH, 2018, 78 (04)
12345